Baird Financial Group Inc. Purchases New Position in BridgeBio Pharma, Inc. $BBIO
MarketBeat
Baird Financial Group Inc. purchased a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 41,326 shares of the company's stock, valued
NASDAQ:BBIO